Centessa Pharmaceuticals
CNTA | NASDAQ
$40.50
$0 (0.00%)
At close: Jun 25, 2026, 4:00 PM ET
Institutional Ownership
Net InflowTotal Institutions
157
Total Ownership
107.15%
Capital Flow
+$483.29M
Shares Change
+15.43M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
41
Increased Positions
86
Reduced Positions
50
Closed Positions
23
New (41)
Increased (86)
Reduced (50)
Closed (23)
Options Sentiment & Activity
bullishPut/Call Ratio
0.507
Call Flow
476,400
Put Flow
241,500
Calls (66%)
Puts (34%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Maverick Capital LTD | 1.38% +12.82% | 0.69% | 1.85M | 75.11M | |
| Point72 Asset Management LP | 0.23% 0.00% | 0.01% | 307.36K | 12.45M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Medicxi Ventures Management (jersey) Ltd | 14.88% -0.36% | 59.80% -8.05% | 19.96M 0.00% | 499.28M +3.13% | |
| Avoro Capital Advisors LLC | 10.85% +34.19% | 3.50% +3.30% | 14.56M +34.67% | 364.03M +38.89% | |
| Adage Capital Partners Gp, L.l.c. | 8.41% +12.02% | 0.43% +10.79% | 11.28M +12.42% | 282.16M +15.95% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove CNTA